Jari Sundström
Publications
- EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer (2017)
- International Journal of Cancer
(A1 Refereed original research article in a scientific journal) - (2017)
- PLoS ONE
(A1 Refereed original research article in a scientific journal) - (2017)
- Developmental Cell
(A1 Refereed original research article in a scientific journal) - (2016)
- BMC Cancer
(A1 Refereed original research article in a scientific journal) - (2015)
- Journal of Histochemistry and Cytochemistry
(A1 Refereed original research article in a scientific journal) - (2015)
- Cancer Medicine
(A1 Refereed original research article in a scientific journal) - (2014)
- PLoS ONEWorld Journal of Gastroenterology
(A1 Refereed original research article in a scientific journal) - (2013)
- Human Pathology
(A1 Refereed original research article in a scientific journal) - Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence (2012)
(A1 Refereed original research article in a scientific journal) - MicroRNA profiling differentiates colorectal cancer according to KRAS status2012
- Genes, Chromosomes and Cancer
(A1 Refereed original research article in a scientific journal) - (2012)
- Cancer Genetics
(A1 Refereed original research article in a scientific journal) - Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain? (2012)
- British Journal of Cancer
- (2012)
- International Journal of Cancer
(A1 Refereed original research article in a scientific journal) - (2011)
- Anticancer ResearchBritish Journal of Cancer
(A1 Refereed original research article in a scientific journal) - (2011)
(A1 Refereed original research article in a scientific journal) - Epidermaalisen kasvutekijäreseptorigeenin kopiomäärä ennustaa vasta-ainehoidon tehoa suolistosyövässä (2011)
- Duodecim
(A1 Refereed original research article in a scientific journal) - Pronounced Tumour Regression after Radiotherapy is Associated with Negative/Weak Glucose Transporter-1 Expression in Rectal Cancer (2011)
- Anticancer Research
(A1 Refereed original research article in a scientific journal) - Securin identifies a subgroup of patients with poor outcome in rectal cancer treated with long-course (chemo) radiotherapy (2011)
- Acta Oncologica
(A1 Refereed original research article in a scientific journal) - Preoperative radiotherapy downregulates the nuclear expression of hypoxia-inducible factor-1 alpha in rectal cancer (2010)
- Scandinavian Journal of Gastroenterology
(A1 Refereed original research article in a scientific journal) - Retention of prolyl hydroxylase PHD2 in the cytoplasm prevents PHD2-induced anchorage-independent carcinoma cell growth (2010)
- Experimental Cell Research
(A1 Refereed original research article in a scientific journal)